Myeloma Treatment and Research Update
Dr. William Bensinger, Director of the Autologous Marrow Transplant Program, at the Seattle Cancer Care Alliance and a renowned myeloma specialist, gives us a hopeful message of how new medicines are adding years to the lives of myeloma patients. He reviews existing therapies and explains the latest strategies for using medicines together for greater effect. Dr. Bensinger also explains other medicines that may be approved by the FDA soon and areas of research including gene therapy and vaccines.
Experts & Guests
William Bensinger, M.D.
Director, Autologous Marrow Transplant Program, Seattle Cancer Care AllianceDr. Bensinger is Director of the Autologous Marrow Transplant Program at Seattle Cancer Care Alliance, a member in the Clinical Research Division at Fred Hutchinson Cancer Research Center, and a Professor of Medicine at the University of Washington. He works on the diagnosis and treatment of blood disorders such as leukemia, lymphoma and myeloma, using treatments including autologous stem cell... more >